EP Wealth Advisors LLC purchased a new position in Corteva, Inc. (NYSE:CTVA - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 27,374 shares of the company's stock, valued at approximately $2,318,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. William B. Walkup & Associates Inc. lifted its holdings in shares of Corteva by 2.9% during the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company's stock worth $373,000 after acquiring an additional 126 shares during the period. Wilkerson Advisory Group LLC grew its holdings in Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company's stock valued at $177,000 after purchasing an additional 133 shares during the period. AdvisorNet Financial Inc grew its holdings in Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company's stock valued at $477,000 after purchasing an additional 135 shares during the period. First Horizon Corp increased its position in Corteva by 9.2% during the first quarter. First Horizon Corp now owns 1,600 shares of the company's stock worth $134,000 after purchasing an additional 135 shares during the last quarter. Finally, Aviance Capital Partners LLC increased its position in Corteva by 1.3% during the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company's stock worth $922,000 after purchasing an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.
Corteva Price Performance
Shares of NYSE CTVA opened at $81.84 on Friday. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The business has a 50-day moving average of $82.13 and a 200-day moving average of $80.21. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The company has a market capitalization of $54.60 billion, a price-to-earnings ratio of 54.20, a PEG ratio of 2.51 and a beta of 0.57.
Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company's revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter last year, the firm earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva's dividend payout ratio (DPR) is 47.68%.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on CTVA shares. CICC Research lifted their price target on shares of Corteva from $80.00 to $93.00 and gave the company an "outperform" rating in a report on Wednesday, May 13th. Royal Bank Of Canada upped their price objective on Corteva from $97.00 to $103.00 and gave the stock an "outperform" rating in a report on Tuesday, July 21st. BMO Capital Markets increased their target price on Corteva from $95.00 to $100.00 and gave the stock an "outperform" rating in a research report on Monday, August 3rd. Barclays lifted their target price on Corteva from $84.00 to $91.00 and gave the company an "overweight" rating in a report on Thursday, June 11th. Finally, Weiss Ratings downgraded Corteva from a "hold (c+)" rating to a "hold (c)" rating in a research report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $91.50.
Get Our Latest Research Report on CTVA
Corteva Profile
(
Free Report)
Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
